GT
49
-3
MTCH
44
-2
BEN
41
-9
EXC
58
11
KSS
47
-4
MAC
71
-4
HPE
44
-2
K
42
-3
PRU
59
2
DNB
46
-2
HD
35
-11
DRI
63
3
CAH
43
2
ZION
55
2
RL
76
3
FLS
75
8
AA
53
5
MNST
59
2
HES
68
2
CB
57
3
GT
49
-3
MTCH
44
-2
BEN
41
-9
EXC
58
11
KSS
47
-4
MAC
71
-4
HPE
44
-2
K
42
-3
PRU
59
2
DNB
46
-2
HD
35
-11
DRI
63
3
CAH
43
2
ZION
55
2
RL
76
3
FLS
75
8
AA
53
5
MNST
59
2
HES
68
2
CB
57
3
Financhill
Back

Finch Therapeutics Group 10K Form

Sell
10

FNCH
Finch Therapeutics Group

Last Price:
2.02
Seasonality Move:
-2.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive FNCH News And Ratings

See the #1 stock for the next 7 days that we like better than FNCH

FNCH Financial Statistics

Sales & Book Value

Annual Sales: $107K
Cash Flow: $-4.36M
Price / Cash Flow: 0
Annual Sales: $11.86
Price / Book: 0.16

Profitability

EPS (TTM): -10.14000
Net Income (TTM): $-16.28M
Gross Margin: $7.72M
Return on Equity: 0%
Return on Assets: 0%

Finch Therapeutics Group Earnings Forecast

Key Finch Therapeutics Group Financial Ratios

  • The Gross Profit Margin over the past 2 years for FNCH is 100.01%.
  • The Selling, General & Administrative Expenses for FNCH have been equal to 25,149.53% of Gross Profit Margin.
  • The Research & Development expenses have been 6,728.04% of Revenue.
  • The Net Earning history of FNCH is -69,863.55% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

Finch Therapeutics Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: FNCH
Website: finchtherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

FNCH Technical Analysis vs Fundamental Analysis

Sell
10
Finch Therapeutics Group (FNCH) is a Sell

Is Finch Therapeutics Group a Buy or a Sell?